These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15625860)

  • 21. Effect of Ala-2-D-Trp-8-D-Cys-14-somatostatin on the arginine induced release of insulin, GH and glucagon in normal men.
    Gonzalez-Barcena D; Mendoza F; Medina R; Coy DH; Murphy WA; Schally AV
    Endocr Res; 1984; 10(1):39-48. PubMed ID: 6146518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of intravenous or intracerebroventricular injections of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on GH release in conscious, freely moving male rats.
    Yagi H; Kaji H; Sato M; Okimura Y; Chihara K
    Neuroendocrinology; 1996 Feb; 63(2):198-206. PubMed ID: 9053785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of growth hormone and glucagon release by Phe-4-somatostatin in patients with acromegaly.
    Charro AL; Cabranes JA; Lafuente A; Diaz-Salgado C; Cordero M; Almoguera I; Comaru-Schally AM; Meyers CA; Coy DH; Schally AV
    Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):432-44. PubMed ID: 6150529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
    Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
    J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Natural peptides and their analogs. XXXV. Synthesis and properties of [Ala5, Orn9]somatostatin].
    Shvachkin IuP; Smirnova AP; Ermak NM; Fedotov VP; Sadovnikova NV
    Bioorg Khim; 1985 Aug; 11(8):1026-36. PubMed ID: 2865960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatostatin: analogs with selected biological activities.
    Brown M; Rivier J; Vale W
    Science; 1977 Jun; 196(4297):1467-9. PubMed ID: 867045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel long-acting somatostatin analog with endocrine selectivity: potent suppression of growth hormone but not of insulin.
    Afargan M; Janson ET; Gelerman G; Rosenfeld R; Ziv O; Karpov O; Wolf A; Bracha M; Shohat D; Liapakis G; Gilon C; Hoffman A; Stephensky D; Oberg K
    Endocrinology; 2001 Jan; 142(1):477-86. PubMed ID: 11145612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic beta-amino acid.
    Sukopp M; Schwab R; Marinelli L; Biron E; Heller M; Várkondi E; Pap A; Novellino E; Kéri G; Kessler H
    J Med Chem; 2005 Apr; 48(8):2916-26. PubMed ID: 15828830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potent, highly selective inhibition of growth hormone secretion by position 4 somatostatin analogs.
    Murphy WA; Meyers CA; Coy DH
    Endocrinology; 1981 Aug; 109(2):491-5. PubMed ID: 6113951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of receptors for somatostatin in various tumors using different analogs.
    Srkalovic G; Cai RZ; Schally AV
    J Clin Endocrinol Metab; 1990 Mar; 70(3):661-9. PubMed ID: 1968467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel heptapeptide somatostatin analog displays anti-tumor activity independent of effects on growth hormone secretion.
    Murphy WA; Taylor JE; Moreau JP; Coy DH
    Pept Res; 1989; 2(1):128-32. PubMed ID: 2577697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological actions of prosomatostatin.
    Meyers CA; Murphy WA; Redding TW; Coy DH; Schally AV
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6171-4. PubMed ID: 6108563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
    Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
    J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the mechanism of somatostatin action on insulin release. V. Effect of somatostatin analogues on arginine induced release of insulin and glucagon from the perfused rat pancreas.
    Efendić S; Lins PE; Luft R; Sievertsson H; Westin-Sjödal G
    Acta Endocrinol (Copenh); 1977 Jul; 85(3):579-86. PubMed ID: 194446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic hexa- and pentapeptide somatostatin analogues with reduced gastric inhibitory activity.
    Hirst BH; Arilla E; Coy DH; Shaw B
    Peptides; 1984; 5(5):857-60. PubMed ID: 6150467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological activity of somatostatin and somatostatin analogs on inhibtion of arginine-induced insulin and glucagon release in the rat.
    Brown M; Rivier J; Vale W
    Endocrinology; 1976 Feb; 98(2):336-43. PubMed ID: 813991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release.
    Meyers C; Arimura A; Gordin A; Fernandez-Durango R; Coy DH; Schally AV; Drouin J; Ferland L; Beaulieu M; Labrie F
    Biochem Biophys Res Commun; 1977 Jan; 74(2):630-6. PubMed ID: 836315
    [No Abstract]   [Full Text] [Related]  

  • 38. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.
    Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T
    Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatostatin analogs. Relative importance of the disulfide bridge and of the Ala-Gly side chain for biological activity.
    Rivier J; Brazeau P; Vale W; Guillemin R
    J Med Chem; 1975 Feb; 18(2):123-6. PubMed ID: 1091734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, in vitro biological activity, hydrolytic stability and docking of new analogs of BIM-23052 containing halogenated amino acids.
    Danalev D; Borisova D; Yaneva S; Georgieva M; Balacheva A; Dzimbova T; Iliev I; Pajpanova T; Zaharieva Z; Givechev I; Naydenova E
    Amino Acids; 2020 Dec; 52(11-12):1581-1592. PubMed ID: 33215308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.